Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Bethge, Peter Dreger, Eva-Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P. McLornan, Ibrahim Yakoub-Agha, Mohamad Mohty

Open source

DOI: 10.1038/s41409-024-02241-2
Published: 2024-02-21
Container: Bone Marrow Transplantation
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41409-024-02241-2,
  title = {Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison},
  author = {Dietrich Wilhelm Beelen and Simona Iacobelli and Linda Koster and Dirk-Jan Eikema and Anja van Biezen and Friedrich Stölzel and Fabio Ciceri and Wolfgang Bethge and Peter Dreger and Eva-Maria Wagner-Drouet and Péter Reményi and Matthias Stelljes and Miroslaw Markiewicz and Donal P. McLornan and Ibrahim Yakoub-Agha and Mohamad Mohty},
  year = {2024},
  journal = {Bone Marrow Transplantation},
  doi = {10.1038/s41409-024-02241-2},
  url = {https://doi.org/10.1038/s41409-024-02241-2}
}

RIS

TY  - JOUR
TI  - Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison
AU  - Dietrich Wilhelm Beelen
AU  - Simona Iacobelli
AU  - Linda Koster
AU  - Dirk-Jan Eikema
AU  - Anja van Biezen
AU  - Friedrich Stölzel
AU  - Fabio Ciceri
AU  - Wolfgang Bethge
AU  - Peter Dreger
AU  - Eva-Maria Wagner-Drouet
AU  - Péter Reményi
AU  - Matthias Stelljes
AU  - Miroslaw Markiewicz
AU  - Donal P. McLornan
AU  - Ibrahim Yakoub-Agha
AU  - Mohamad Mohty
PY  - 2024
JO  - Bone Marrow Transplantation
DO  - 10.1038/s41409-024-02241-2
UR  - https://doi.org/10.1038/s41409-024-02241-2
ER  -

APA

Beelen, D. W., Iacobelli, S., Koster, L., Eikema, D., Biezen, A. V., Stölzel, F., Ciceri, F., Bethge, W., Dreger, P., Wagner-Drouet, E., Reményi, P., Stelljes, M., Markiewicz, M., McLornan, D. P., Yakoub-Agha, I., & Mohty, M. (2024). Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02241-2

Source records

crossref · retrieved 2026-09-25T13:55:20.908Z